Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

NARecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

March 20, 2027

Study Completion Date

May 20, 2027

Conditions

Proliferative Diabetic Retinopathy - High Risk

Interventions

PROCEDURE

Bevacizumab

Bevacizumab will be given immediately after surgery in the Treatment Group

Trial Locations (1)

RECRUITING

Sky Vision, Querétaro City

All Listed Sponsors

lead

Christian Ophthalmic Surgery Expedition Network

OTHER